Dash S. Correction to: Hepatocellular carcinoma xenograft supports HCV replication: A mouse model for evaluating antivirals. World J Gastroenterol 2025; 31(23): 108472 [DOI: 10.3748/wjg.v31.i23.108472]
Corresponding Author of This Article
Srikanta Dash, PhD, Full Professor, Department of Pathology and Laboratory Medicine, Tulane University Health Sciences Center, 1430 Tulane Ave, New Orleans, LA 70112, United States. sdash@tulane.edu
Research Domain of This Article
Infectious Diseases
Article-Type of This Article
Correction
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Jun 21, 2025; 31(23): 108472 Published online Jun 21, 2025. doi: 10.3748/wjg.v31.i23.108472
Correction to: Hepatocellular carcinoma xenograft supports HCV replication: A mouse model for evaluating antivirals
Srikanta Dash
Srikanta Dash, Department of Pathology and Laboratory Medicine, Tulane University Health Sciences Center, New Orleans, LA 70112, United States
Author contributions: Dash S solely contributed to this correction.
Conflict-of-interest statement: The author reports no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Srikanta Dash, PhD, Full Professor, Department of Pathology and Laboratory Medicine, Tulane University Health Sciences Center, 1430 Tulane Ave, New Orleans, LA 70112, United States. sdash@tulane.edu
Received: April 15, 2025 Revised: May 8, 2025 Accepted: June 4, 2025 Published online: June 21, 2025 Processing time: 66 Days and 15.5 Hours
Abstract
This is an erratum to the published paper titled “Hepatocellular carcinoma xenograft supports HCV replication: A mouse model for evaluating antivirals”. Figure 9 panels shown weeks 2 and weeks 4 were duplicated. This correction is requested to ensure the accuracy of the information provided in this article.
Core Tip: This correction is to: Hazari S, Hefler HJ, Chandra PK, Poat B, Gunduz F, Ooms T, Wu T, Balart LA, Dash S. Hepatocellular carcinoma xenograft supports HCV replication: a mouse model for evaluating antivirals. World J Gastroenterol 2011; 17 (3): 300-312, PMID: 21253388 DOI: 10.3748/wjg.v17.i3.300. The purpose of figure 9 in this article is to show that interferon treatment does not reduce tumor growth. The histology panel shown in weeks 2 and 4 were duplicated. As the corresponding author, I am submitting a corrected figure. This correction is requested to ensure the accuracy of the information provided in this article. This correction does not impact the conclusion of the manuscript.
